Literature DB >> 23918092

Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.

Stephen P Badham1, Claire V Hutchinson.   

Abstract

BACKGROUND: People who suffer from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) often report that their eye movements are sluggish and that they have difficulties tracking moving objects. However, descriptions of these visual problems are based solely on patients' self-reports of their subjective visual experiences, and there is a distinct lack of empirical evidence to objectively verify their claims. This paper presents the first experimental research to objectively examine eye movements in those suffering from ME/CFS.
METHODS: Patients were assessed for ME/CFS symptoms and were compared to age, gender, and education matched controls for their ability to generate saccades and smooth pursuit eye movements.
RESULTS: Patients and controls exhibited similar error rates and saccade latencies (response times) on prosaccade and antisaccade tasks. Patients showed relatively intact ability to accurately fixate the target (prosaccades), but were impaired when required to focus accurately in a specific position opposite the target (antisaccades). Patients were most markedly impaired when required to direct their gaze as closely as possible to a smoothly moving target (smooth pursuit).
CONCLUSIONS: It is hypothesised that the effects of ME/CFS can be overcome briefly for completion of saccades, but that continuous pursuit activity (accurately tracking a moving object), even for a short time period, highlights dysfunctional eye movement behaviour in ME/CFS patients. Future smooth pursuit research may elucidate and improve diagnosis of ME/CFS.

Entities:  

Mesh:

Year:  2013        PMID: 23918092     DOI: 10.1007/s00417-013-2431-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Effects of lithium treatment on eye movements.

Authors:  P S Holzman; C O'Brian; C Waternaux
Journal:  Biol Psychiatry       Date:  1991-05-15       Impact factor: 13.382

2.  Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome.

Authors:  Lucile Capuron; Leonie Welberg; Christine Heim; Dieter Wagner; Laura Solomon; Dimitris A Papanicolaou; R Cameron Craddock; Andrew H Miller; William C Reeves
Journal:  Neuropsychopharmacology       Date:  2006-01-04       Impact factor: 7.853

3.  Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: a BOLD fMRI study of verbal working memory.

Authors:  G Lange; J Steffener; D B Cook; B M Bly; C Christodoulou; W-C Liu; J Deluca; B H Natelson
Journal:  Neuroimage       Date:  2005-04-07       Impact factor: 6.556

4.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

5.  Impaired cardiovascular response to standing in chronic fatigue syndrome.

Authors:  Kieren G Hollingsworth; David E J Jones; Roy Taylor; Andrew M Blamire; Julia L Newton
Journal:  Eur J Clin Invest       Date:  2010-05-23       Impact factor: 4.686

6.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

7.  Smooth pursuit in schizophrenia: a meta-analytic review of research since 1993.

Authors:  Gillian A O'Driscoll; Brandy L Callahan
Journal:  Brain Cogn       Date:  2008-10-09       Impact factor: 2.310

8.  Attention and verbal learning in patients with chronic fatigue syndrome.

Authors:  V Michiels; R Cluydts; B Fischler
Journal:  J Int Neuropsychol Soc       Date:  1998-09       Impact factor: 2.892

Review 9.  Chronic fatigue syndrome and the central nervous system.

Authors:  R Chen; F X Liang; J Moriya; J Yamakawa; H Sumino; T Kanda; T Takahashi
Journal:  J Int Med Res       Date:  2008 Sep-Oct       Impact factor: 1.671

10.  Cognitive functioning in chronic fatigue syndrome: a meta-analysis.

Authors:  S J Cockshell; J L Mathias
Journal:  Psychol Med       Date:  2010-01-05       Impact factor: 7.723

View more
  7 in total

Review 1.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

2.  The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.

Authors:  Frank N M Twisk
Journal:  Front Physiol       Date:  2014-03-27       Impact factor: 4.566

Review 3.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

4.  Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME).

Authors:  Rachel L Wilson; Kevin B Paterson; Victoria McGowan; Claire V Hutchinson
Journal:  Front Psychol       Date:  2018-08-17

5.  The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology.

Authors:  Mieke Hulens; Ricky Rasschaert; Greet Vansant; Ingeborg Stalmans; Frans Bruyninckx; Wim Dankaerts
Journal:  J Pain Res       Date:  2018-12-10       Impact factor: 3.133

6.  Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME).

Authors:  Nadia S Ahmed; Irene Gottlob; Frank A Proudlock; Claire V Hutchinson
Journal:  Vision (Basel)       Date:  2018-01-17

7.  Oculomotor, vestibular, reaction time, and cognitive tests as objective measures of neural deficits in patients post COVID-19 infection.

Authors:  Kevin M Kelly; R Anghinah; A Kullmann; R C Ashmore; A S Synowiec; L C Gibson; L Manfrinati; A de Araújo; R R Spera; S M D Brucki; R L Tuma; A Braverman; A Kiderman
Journal:  Front Neurol       Date:  2022-09-12       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.